{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:05:57Z","timestamp":1778526357251,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several inflammation-based prognostic scores emerged in various types of cancer to predict clinical outcomes. So far, no accurate pre-treatment scoring systems exist for patients with thymic epithelial tumors (TETs), comprising thymomas and thymic carcinomas (TCs). Therefore, we sought to test the prognostic value of different clinical composite scores and their components, identify optimal cut-off values for TETs as well as combine predictive components to new suitable prognostic scores. One hundred eighty-four patients with TETs undergoing surgical tumor resection were analyzed. A significant advantage in Freedom-from-Recurrence and\/or Cause-specific survival (CSS) was evident for patients with high Advanced-Lung- Cancer-Inflammation-Index, low CRP-Fibrinogen-Score (CFS), low Glasgow-Prognostic-Score (GPS), low high-sensitivity-modified GPS, low TET-adapted GPS (TET-aGPS) and low Systemic-Immune-Inflammation Index. On multivariable analysis high TET-aGPS (HR\u2009=\u200914.9;p\u2009=\u20090.001), incomplete resection status (HR\u2009=\u200913.5;p\u2009=\u20090.001) and TC (HR\u2009=\u200926.0;p\u2009=\u20090.001) were significant independent prognostic factors for worse CSS. The CFS had the highest coefficient of determination (R<jats:sup>2<\/jats:sup>\u2009=\u20090.188) to predict tumor recurrence of all composite scores, comprising CRP (R<jats:sup>2<\/jats:sup>\u2009=\u20090.141) and fibrinogen (R<jats:sup>2<\/jats:sup>\u2009=\u20090.158), the best single factor predictors. Inflammation-based prognostic scores and selected components are suitable to predict survival and\/or tumor recurrence in TET patients undergoing primary surgery. Due to excellent long-term survival and frequent tumor recurrence, cut-off values were tailored to increase prognostic power.<\/jats:p>","DOI":"10.1038\/s41598-019-54906-4","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T11:03:02Z","timestamp":1575889382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical prognostic scores for patients with thymic epithelial tumors"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9378-5000","authenticated-orcid":false,"given":"Cecilia","family":"Veraar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1161-4871","authenticated-orcid":false,"given":"Stefan","family":"Janik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9893-5485","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Thanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarence","family":"Veraar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Mouhieddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3555-8672","authenticated-orcid":false,"given":"Ana-Iris","family":"Schiefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonhard","family":"M\u00fcllauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-4337","authenticated-orcid":false,"given":"Martin","family":"Dworschak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8761-3517","authenticated-orcid":false,"given":"Hendrik Jan","family":"Ankersmit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6037-5475","authenticated-orcid":false,"given":"Bernhard","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"54906_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","volume":"44","author":"WK de Jong","year":"2008","unstructured":"de Jong, W. K. et al. Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer 44, 123\u2013130, https:\/\/doi.org\/10.1016\/j.ejca.2007.11.004 (2008).","journal-title":"Eur J Cancer"},{"key":"54906_CR2","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","volume":"5","author":"EA Engels","year":"2010","unstructured":"Engels, E. A. Epidemiology of thymoma and associated malignancies. J Thorac Oncol 5, S260\u2013265, https:\/\/doi.org\/10.1097\/JTO.0b013e3181f1f62d (2010).","journal-title":"J Thorac Oncol"},{"key":"54906_CR3","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"A Masaoka","year":"1981","unstructured":"Masaoka, A., Monden, Y., Nakahara, K. & Tanioka, T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 48, 2485\u20132492 (1981).","journal-title":"Cancer"},{"key":"54906_CR4","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","volume":"10","author":"A Marx","year":"2015","unstructured":"Marx, A. et al. The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes. J Thorac Oncol 10, 1383\u20131395, https:\/\/doi.org\/10.1097\/JTO.0000000000000654 (2015).","journal-title":"J Thorac Oncol"},{"key":"54906_CR5","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1097\/JTO.0000000000000291","volume":"9","author":"K Kondo","year":"2014","unstructured":"Kondo, K. et al. The IASLC\/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9, S81\u201387, https:\/\/doi.org\/10.1097\/JTO.0000000000000291 (2014).","journal-title":"J Thorac Oncol"},{"key":"54906_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fimmu.2017.00071","volume":"8","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q., Zhu, B. & Li, Y. Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy. Front Immunol 8, 71, https:\/\/doi.org\/10.3389\/fimmu.2017.00071 (2017).","journal-title":"Front Immunol"},{"key":"54906_CR7","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1016\/j.cllc.2015.03.005","volume":"16","author":"X He","year":"2015","unstructured":"He, X. et al. Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer. Clin Lung Cancer 16, e165\u2013171, https:\/\/doi.org\/10.1016\/j.cllc.2015.03.005 (2015).","journal-title":"Clin Lung Cancer"},{"key":"54906_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/icvts\/ivx329","volume":"26","author":"M Tomita","year":"2018","unstructured":"Tomita, M., Ayabe, T. & Nakamura, K. The advanced lung cancer inflammation index is an independent prognostic factor after surgical resection in patients with non-small-cell lung cancer. Interact Cardiovasc Thorac Surg 26, 288\u2013292, https:\/\/doi.org\/10.1093\/icvts\/ivx329 (2018).","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"54906_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.9738\/INTSURG-D-13-00118.1","volume":"99","author":"T Nozoe","year":"2014","unstructured":"Nozoe, T., Matono, R., Ijichi, H., Ohga, T. & Ezaki, T. Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma. Int Surg 99, 512\u2013517, https:\/\/doi.org\/10.9738\/INTSURG-D-13-00118.1 (2014).","journal-title":"Int Surg"},{"key":"54906_CR10","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.3748\/wjg.v23.i34.6261","volume":"23","author":"JH Chen","year":"2017","unstructured":"Chen, J. H. et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol 23, 6261\u20136272, https:\/\/doi.org\/10.3748\/wjg.v23.i34.6261 (2017).","journal-title":"World J Gastroenterol"},{"key":"54906_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10147-013-0613-y","volume":"19","author":"Y Ikuta","year":"2014","unstructured":"Ikuta, Y. et al. The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers. Int J Clin Oncol 19, 629\u2013633, https:\/\/doi.org\/10.1007\/s10147-013-0613-y (2014).","journal-title":"Int J Clin Oncol"},{"key":"54906_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000362601","volume":"87","author":"S Takeno","year":"2014","unstructured":"Takeno, S. et al. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer. Oncology 87, 205\u2013214, https:\/\/doi.org\/10.1159\/000362601 (2014).","journal-title":"Oncology"},{"key":"54906_CR13","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1038\/sj.bjc.6601789","volume":"90","author":"LM Forrest","year":"2004","unstructured":"Forrest, L. M., McMillan, D. C., McArdle, C. S., Angerson, W. J. & Dunlop, D. J. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 90, 1704\u20131706, https:\/\/doi.org\/10.1038\/sj.bjc.6601789 (2004).","journal-title":"Br J Cancer"},{"key":"54906_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4103\/0973-1482.176168","volume":"12","author":"J Osugi","year":"2016","unstructured":"Osugi, J. et al. Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer. J Cancer Res Ther 12, 945\u2013951, https:\/\/doi.org\/10.4103\/0973-1482.176168 (2016).","journal-title":"J Cancer Res Ther"},{"key":"54906_CR15","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu, B. et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res 20, 6212\u20136222, https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0442 (2014).","journal-title":"Clin Cancer Res"},{"key":"54906_CR16","first-page":"61","volume":"1","author":"1951 Annual Meeting of the American Anaesthesiology Society","year":"1952","unstructured":"1951 Annual Meeting of the American Anaesthesiology Society. Anaesthesist 1, 61 (1952).","journal-title":"Anaesthesist"},{"key":"54906_CR17","doi-asserted-by":"publisher","first-page":"21861","DOI":"10.18632\/oncotarget.25076","volume":"9","author":"S Janik","year":"2018","unstructured":"Janik, S. et al. Prognostic and diagnostic impact of fibrinogen, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio on thymic epithelial tumors outcome. Oncotarget 9, 21861\u201321875, https:\/\/doi.org\/10.18632\/oncotarget.25076 (2018).","journal-title":"Oncotarget"},{"key":"54906_CR18","doi-asserted-by":"publisher","first-page":"47090","DOI":"10.18632\/oncotarget.17478","volume":"8","author":"S Janik","year":"2017","unstructured":"Janik, S. et al. Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis. Oncotarget 8, 47090\u201347102, https:\/\/doi.org\/10.18632\/oncotarget.17478 (2017).","journal-title":"Oncotarget"},{"key":"54906_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ssu.10016","volume":"21","author":"M Gospodarowicz","year":"2003","unstructured":"Gospodarowicz, M. & O\u2019Sullivan, B. Prognostic factors in cancer. Semin Surg Oncol 21, 13\u201318, https:\/\/doi.org\/10.1002\/ssu.10016 (2003).","journal-title":"Semin Surg Oncol"},{"key":"54906_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ijsu.2015.04.079","volume":"18","author":"NJ Hackett","year":"2015","unstructured":"Hackett, N. J., De Oliveira, G. S., Jain, U. K. & Kim, J. Y. ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int J Surg 18, 184\u2013190, https:\/\/doi.org\/10.1016\/j.ijsu.2015.04.079 (2015).","journal-title":"Int J Surg"},{"key":"54906_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-158","volume":"13","author":"SH Jafri","year":"2013","unstructured":"Jafri, S. H., Shi, R. & Mills, G. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer 13, 158, https:\/\/doi.org\/10.1186\/1471-2407-13-158 (2013).","journal-title":"BMC Cancer"},{"key":"54906_CR22","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/sj.bjc.6601242","volume":"89","author":"LM Forrest","year":"2003","unstructured":"Forrest, L. M., McMillan, D. C., McArdle, C. S., Angerson, W. J. & Dunlop, D. J. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89, 1028\u20131030, https:\/\/doi.org\/10.1038\/sj.bjc.6601242 (2003).","journal-title":"Br J Cancer"},{"key":"54906_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-3-319-40389-2_3","volume":"170","author":"GA Woodard","year":"2016","unstructured":"Woodard, G. A., Jones, K. D. & Jablons, D. M. Lung Cancer Staging and Prognosis. Cancer Treat Res 170, 47\u201375, https:\/\/doi.org\/10.1007\/978-3-319-40389-2_3 (2016).","journal-title":"Cancer Treat Res"},{"issue":"3","key":"54906_CR24","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.athoracsur.2004.03.097","volume":"78","author":"Moo Suk Park","year":"2004","unstructured":"Park, M. S. et al. Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Ann Thorac Surg 78, 992\u2013997, discussion 997\u2013998, https:\/\/doi.org\/10.1016\/j.athoracsur.2004.03.097 (2004).","journal-title":"The Annals of Thoracic Surgery"},{"key":"54906_CR25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/JTO.0000000000000128","volume":"9","author":"E Ruffini","year":"2014","unstructured":"Ruffini, E. et al. Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database. J Thorac Oncol 9, 541\u2013548, https:\/\/doi.org\/10.1097\/JTO.0000000000000128 (2014).","journal-title":"J Thorac Oncol"},{"key":"54906_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jtcvs.2008.05.046","volume":"137","author":"KM Sarraf","year":"2009","unstructured":"Sarraf, K. M. et al. Neutrophil\/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 137, 425\u2013428, https:\/\/doi.org\/10.1016\/j.jtcvs.2008.05.046 (2009).","journal-title":"J Thorac Cardiovasc Surg"},{"key":"54906_CR27","first-page":"1875","volume":"6","author":"AK Eerola","year":"2000","unstructured":"Eerola, A. K., Soini, Y. & Paakko, P. A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. Clin Cancer Res 6, 1875\u20131881 (2000).","journal-title":"Clin Cancer Res"},{"key":"54906_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0169-5002(99)00072-0","volume":"26","author":"AK Eerola","year":"1999","unstructured":"Eerola, A. K., Soini, Y. & Paakko, P. Tumour infiltrating lymphocytes in relation to tumour angiogenesis, apoptosis and prognosis in patients with large cell lung carcinoma. Lung Cancer 26, 73\u201383 (1999).","journal-title":"Lung Cancer"},{"key":"54906_CR29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0889-8588(02)00024-2","volume":"16","author":"M Maltoni","year":"2002","unstructured":"Maltoni, M. & Amadori, D. Prognosis in advanced cancer. Hematol Oncol Clin North Am 16, 715\u2013729 (2002).","journal-title":"Hematol Oncol Clin North Am"},{"key":"54906_CR30","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1016\/S0272-6386(98)70174-X","volume":"32","author":"JY Yeun","year":"1998","unstructured":"Yeun, J. Y. & Kaysen, G. A. Factors influencing serum albumin in dialysis patients. Am J Kidney Dis 32, S118\u2013125 (1998).","journal-title":"Am J Kidney Dis"},{"key":"54906_CR31","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jtho.2016.04.029","volume":"11","author":"M Yotsukura","year":"2016","unstructured":"Yotsukura, M. et al. Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non-Small Cell Lung Cancer. J Thorac Oncol 11, 1311\u20131318, https:\/\/doi.org\/10.1016\/j.jtho.2016.04.029 (2016).","journal-title":"J Thorac Oncol"},{"key":"54906_CR32","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1097\/IGC.0000000000000485","volume":"25","author":"T Nishida","year":"2015","unstructured":"Nishida, T. et al. The Glasgow Prognostic Score Determined During Concurrent Chemoradiotherapy Is an Independent Predictor of Survival for Cervical Cancer. Int J Gynecol Cancer 25, 1306\u20131314, https:\/\/doi.org\/10.1097\/IGC.0000000000000485 (2015).","journal-title":"Int J Gynecol Cancer"},{"key":"54906_CR33","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00268-014-2844-0","volume":"39","author":"H Shiba","year":"2015","unstructured":"Shiba, H. et al. Glasgow prognostic score predicts outcome after surgical resection of gallbladder cancer. World J Surg 39, 753\u2013758, https:\/\/doi.org\/10.1007\/s00268-014-2844-0 (2015).","journal-title":"World J Surg"},{"key":"54906_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0287-y","volume":"31","author":"T Moriwaki","year":"2014","unstructured":"Moriwaki, T. et al. Glasgow Prognostic Score predicts poor prognosis among advanced biliary tract cancer patients with good performance status. Med Oncol 31, 287, https:\/\/doi.org\/10.1007\/s12032-014-0287-y (2014).","journal-title":"Med Oncol"},{"key":"54906_CR35","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/cncr.28018","volume":"119","author":"MJ Proctor","year":"2013","unstructured":"Proctor, M. J. et al. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study. Cancer 119, 2325\u20132332, https:\/\/doi.org\/10.1002\/cncr.28018 (2013).","journal-title":"Cancer"},{"key":"54906_CR36","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/00042737-200012080-00015","volume":"12","author":"M Schoniger-Hekele","year":"2000","unstructured":"Schoniger-Hekele, M. et al. Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation. Eur J Gastroenterol Hepatol 12, 941\u2013948 (2000).","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"54906_CR37","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/jnci\/djn134","volume":"100","author":"JM Llovet","year":"2008","unstructured":"Llovet, J. M. et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100, 698\u2013711, https:\/\/doi.org\/10.1093\/jnci\/djn134 (2008).","journal-title":"J Natl Cancer Inst"},{"key":"54906_CR38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10555-014-9498-0","volume":"33","author":"DG Menter","year":"2014","unstructured":"Menter, D. G. et al. Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev 33, 231\u2013269, https:\/\/doi.org\/10.1007\/s10555-014-9498-0 (2014).","journal-title":"Cancer Metastasis Rev"},{"key":"54906_CR39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/1097-0142(197408)34:2<389::AID-CNCR2820340224>3.0.CO;2-Z","volume":"34","author":"MA Batata","year":"1974","unstructured":"Batata, M. A., Martini, N., Huvos, A. G., Aguilar, R. I. & Beattie, E. J. Jr. Thymomas: clinicopathologic features, therapy, and prognosis. Cancer 34, 389\u2013396 (1974).","journal-title":"Cancer"},{"key":"54906_CR40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-5223(19)37441-0","volume":"87","author":"F Shamji","year":"1984","unstructured":"Shamji, F. et al. Results of surgical treatment for thymoma. J Thorac Cardiovasc Surg 87, 43\u201347 (1984).","journal-title":"J Thorac Cardiovasc Surg"},{"key":"54906_CR41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejcts.2010.09.042","volume":"40","author":"E Ruffini","year":"2011","unstructured":"Ruffini, E. et al. Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience. Eur J Cardiothorac Surg 40, 146\u2013153, https:\/\/doi.org\/10.1016\/j.ejcts.2010.09.042 (2011).","journal-title":"Eur J Cardiothorac Surg"},{"key":"54906_CR42","doi-asserted-by":"publisher","first-page":"S1691","DOI":"10.1097\/JTO.0b013e3182254ac1","volume":"6","author":"J Huang","year":"2011","unstructured":"Huang, J., Detterbeck, F. C., Wang, Z. & Loehrer, P. J. Sr. Standard outcome measures for thymic malignancies. J Thorac Oncol 6, S1691\u20131697, https:\/\/doi.org\/10.1097\/JTO.0b013e3182254ac1 (2011).","journal-title":"J Thorac Oncol"},{"key":"54906_CR43","unstructured":"Doyle, D. J. & Garmon, E. H. In StatPearls (2018)."},{"key":"54906_CR44","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1590\/S0102-8650201500800000010","volume":"30","author":"MA Henry","year":"2015","unstructured":"Henry, M. A., Lerco, M. M., de Oliveira, W. K., Guerra, A. R. & Rodrigues, M. A. The Glasgow Prognostic Score. An useful tool to predict survival in patients with advanced esophageal squamous cell carcinoma. Acta Cir Bras 30, 580\u2013585, https:\/\/doi.org\/10.1590\/S0102-8650201500800000010 (2015).","journal-title":"Acta Cir Bras"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54906-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T17:09:14Z","timestamp":1671296954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54906-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["54906"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-54906-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"assertion":[{"value":"28 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18581"}}